CA2404078A1 - Immunokine composition and method - Google Patents

Immunokine composition and method Download PDF

Info

Publication number
CA2404078A1
CA2404078A1 CA002404078A CA2404078A CA2404078A1 CA 2404078 A1 CA2404078 A1 CA 2404078A1 CA 002404078 A CA002404078 A CA 002404078A CA 2404078 A CA2404078 A CA 2404078A CA 2404078 A1 CA2404078 A1 CA 2404078A1
Authority
CA
Canada
Prior art keywords
immunokine
hiv
cell
protein
cobratoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002404078A
Other languages
English (en)
French (fr)
Inventor
David D. Mundschenk
Paul F. Reid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESPERANZA PEPTIDE Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2404078A1 publication Critical patent/CA2404078A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002404078A 2000-03-23 2001-03-14 Immunokine composition and method Abandoned CA2404078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53345400A 2000-03-23 2000-03-23
US09/533,454 2000-03-23
PCT/US2001/008150 WO2001070173A2 (en) 2000-03-23 2001-03-14 Immunokine composition and method

Publications (1)

Publication Number Publication Date
CA2404078A1 true CA2404078A1 (en) 2001-09-27

Family

ID=24126023

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002404078A Abandoned CA2404078A1 (en) 2000-03-23 2001-03-14 Immunokine composition and method

Country Status (4)

Country Link
EP (1) EP1272512A4 (de)
AU (1) AU2001249194A1 (de)
CA (1) CA2404078A1 (de)
WO (1) WO2001070173A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008003327A2 (en) * 2006-07-03 2008-01-10 Inagen Aps Immunotoxins for the treatment of diseases related to cmv infection
US7259237B1 (en) 2006-12-29 2007-08-21 Miller Kent D Pan-antiviral peptides
US9220743B2 (en) 2010-01-22 2015-12-29 Nuovo Biologics, Llc Pan-antiviral peptides for protein kinase inhibition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197578B1 (en) * 1996-01-30 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection
CA2253937A1 (en) * 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
US5994515A (en) * 1996-06-25 1999-11-30 Trustees Of The University Of Pennsylvania Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
FR2751658B1 (fr) * 1996-07-26 1998-10-02 Pasteur Institut Utilisation d'une chemokine (sdf-1) ligand pour le recepteur de lestr/fusin/cxcr4 pour prevenir ou traiter l'infection par des virus de type vih
IT1291353B1 (it) * 1997-05-12 1999-01-07 San Raffaele Centro Fond Peptidi con attivita' antivirale

Also Published As

Publication number Publication date
EP1272512A4 (de) 2003-05-07
EP1272512A2 (de) 2003-01-08
WO2001070173A2 (en) 2001-09-27
WO2001070173A3 (en) 2002-03-14
AU2001249194A1 (en) 2001-10-03

Similar Documents

Publication Publication Date Title
US20080248992A1 (en) Immunokine composition and method
AU776910B2 (en) Modifying protein immunogenicity
KR100631766B1 (ko) 폴리펩티드, 그 폴리펩티드를 암호화하는 ｃＤＮＡ 및그들의 용도
KR100393508B1 (ko) 인간 인터루킨 4의 안타고니스트 또는 부분적 아고니스트로서의 신규hIL-4 변이단백질
JPH08506247A (ja) 組換えｃｔｌａ４ポリペプチドおよびその製造方法
JPH09512710A (ja) 組換えフィブリン鎖、フィブリンおよびフィブリン−ホモログ
JP3939747B2 (ja) 可溶性ｃｒ１誘導体
EP1201246A2 (de) Verwendung von Thrombopoietin als Medikament zur Therapie und Vorbeugung der Thrombocytopenie
US20030211465A1 (en) Immunokine composition and method
HU226414B1 (en) Amino-terminally truncated rantes as chemokine antagonists
CN101309934B (zh) 修饰的伴侣蛋白10
AU2013344973A1 (en) Compositions and methods for the treatment of ectodermal dysplasia
CA2404078A1 (en) Immunokine composition and method
US7776526B2 (en) Method for the dissociation of the extracellular haemoglobin molecule of Arenicola marina and the characterization of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains
EP1399549B1 (de) Antikomplement-polypeptide aus den speicheldrüsen der zecken ixodes ricinus
Smith Cloning, characterization, and expression of animal toxin genes for vaccine development
WO1996028469A1 (en) Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof
EP0540575A1 (de) Menschliches meg-csf protein und verfahren
KR100308861B1 (ko) 향균 및 항진균 활성을 갖는 펩타이드
US7358338B2 (en) Heme peptide
WO2024072985A1 (en) Polyvalent vaccines for staphylococcal & streptococcal infection
DE19617202A1 (de) Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
CA2360893A1 (en) Tau-conotoxin peptides
US20070016967A1 (en) Novel IFNgamma-like polypeptides
Mulnix Structure and regulation of expression of the lysozyme gene from the tobacco hornworm, Manduca sexta

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead